NSABP B-42: A Clinical Trial to Determine the Efficacy of Five Years of Letrozole Compared with Placebo in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (AI) or Tamoxifen Followed by an AI in Prolonging Disease-Fr

NSABP B-42: A Clinical Trial to Determine the Efficacy of Five Years of Letrozole Compared with Placebo in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (AI) or Tamoxifen Followed by an AI in Prolonging Disease-Fr

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Clinical Breast Cancer - Volume 7, Issue 5, December 2006, Pages 416-421

Eleftherios P. Mamounas, Barry Lembersky, Jong-Hyeon Jeong, Walter Cronin, Barbara Harkins, Charles Geyer, Donald Lawrence Wickerham, Soonmyung Paik, Joseph Costantino, Norman Wolmark,